ProfileGDS4459 / ENSG00000171953
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 34% 43% 64% 55% 54% 40% 56% 51% 50% 47% 44% 55% 57% 40% 57% 30% 28% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.8934
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.1943
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.0164
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.6755
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.5354
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.0540
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.6856
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.451
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.450
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.3347
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.0844
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.5955
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.7157
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.0940
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.6757
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.7830
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.6728